vufb 16066 has been researched along with griseofulvin in 1 studies
| Studies (vufb 16066) | Trials (vufb 16066) | Recent Studies (post-2010) (vufb 16066) | Studies (griseofulvin) | Trials (griseofulvin) | Recent Studies (post-2010) (griseofulvin) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 3,289 | 115 | 386 |
| Protein | Taxonomy | vufb 16066 (IC50) | griseofulvin (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Homo sapiens (human) | 7.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolezal, P; Holas, T; Hrabálek, A; Klimentová, J; Novotný, J; Vávrová, K; Zbytovská, J | 1 |
1 other study(ies) available for vufb 16066 and griseofulvin
| Article | Year |
|---|---|
Synthesis and enhancing effect of transkarbam 12 on the transdermal delivery of theophylline, clotrimazole, flobufen, and griseofulvin.
Topics: Administration, Cutaneous; Aged; Aminocaproates; Aminocaproic Acid; Butyrates; Carbamates; Clotrimazole; Diffusion Chambers, Culture; Esterases; Female; Griseofulvin; Humans; Male; Molecular Structure; Permeability; Skin; Skin Absorption; Theophylline | 2006 |